Dear Dr. Roach: Does taking Norvasc or any calcium channel blocker reduce or destroy the calcium in the bones, eventually causing osteoporosis? — E.G. Answer: No. Calcium channel blockers, like ...

Ibutilide is the only Food and Drug Administration-approved intravenous drug for the rapid termination of atrial fibrillation and flutter. Its mechanism of action is undecided. The drug has been ...

Basel, Switzerland - Results of a large case-control study, published online February 6 in Neurology, suggest that current use of calcium-channel blockers, but not other antihypertensive agents, is ...

New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these ...

An atomic level analysis has revealed how two classes of calcium channel blockers, widely prescribed for heart disease patients, produce separate therapeutic effects through their actions at different ...

Calcium channel blockers, specifically the short-acting form, appeared associated with increased risk for pancreatic cancer among postmenopausal women, according to a study presented at American ...

Scientists have long wondered why Parkinson’s disease selectively kills a small group of dopamine-generating neurons. A case is building that these vulnerable neurons, found in the substantia nigra ...

Please provide your email address to receive an email when new articles are posted on . CCB users had 39% higher odds of glaucoma on average, as well as thinner inner retinal thickness, vs. non-users.

Dear Dr. Roach: My doctor put me on Norvasc 10 mg to keep my blood pressure normal. Since Norvasc is a calcium-channel-blocking medicine, can I still take my calcium and vitamin D-3 supplements? I was ...

Alzheimer's disease (AD) is the most common cause of dementia but the changes in brain cell function underlying memory loss remains poorly understood. Researchers at the University of Bristol have ...

About The Study: Calcium channel blocker use was adversely associated with glaucoma prevalence in this study of 427,000 adult UK Biobank participants, suggesting that calcium channel blockers may ...